Top

Published in:

01-03-2016 | Overactive Bladder (U Lee, Section Editor)

The Burden of Overactive Bladder on US Public Health

Authors: W. Stuart Reynolds, Jay Fowke, Roger Dmochowski

Published in: Current Bladder Dysfunction Reports | Issue 1/2016

Abstract

Overactive bladder (OAB) is a highly prevalent symptom condition that affects millions of US men and women. Not only can the symptoms of OAB be very bothersome, but OAB can have significant detrimental effects on many aspects of individuals’ lives, representing a particularly impactful health burden to quality of life and productivity. Estimates of the individual and societal costs for the management of OAB continue to rise, particularly as effective treatments remain elusive. As such, OAB represents a significant public health burden to the USA.

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.CrossRefPubMed

Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36. doi:10.1007/s00345-002-0301-4.PubMed

Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology. 2011;77(5):1081–7. doi:10.1016/j.urology.2010.08.039.CrossRefPubMed

Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology. 2012;80(1):90–6. doi:10.1016/j.urology.2012.04.004.CrossRefPubMed

5.••

Coyne KS, Sexton CC, Bell JA, Thompson CL, Dmochowski R, Bavendam T, et al. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL. Neurourol Urodyn. 2013;32(3):230–7. doi:10.1002/nau.22295. The OAB-POLL study is one of the most recent population-based studies to specifically examine the impact of OAB on work productivity and physical activity.CrossRefPubMed

CDC. National Health and Nutrition Examination Study. http://www.cdc.gov/nchs/nhanes.htm. 2015.

Dooley Y, Kenton K, Cao G, Luke A, Durazo-Arvizu R, Kramer H, et al. Urinary incontinence prevalence: results from the National Health and Nutrition Examination Survey. J Urol. 2008;179(2):656–61. doi:10.1016/j.juro.2007.09.081.CrossRefPubMed

Hartmann K, McPheeters M, Biller D, Ward R, McKoy J, Jerome R, et al. Treatment of overactive bladder in women. Evidence report/technology assessment No. 187. Rockville, MD: Agency for Healthcare Research and Quality; 2009.

Coyne KS, Margolis MK, Kopp ZS, Kaplan SA. Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study. Urology. 2012;79(1):95–101. doi:10.1016/j.urology.2011.09.010.CrossRefPubMed

10.

Coyne KS, Wein A, Nicholson S, Kvasz M, Chen CI, Milsom I. Comorbidities and personal burden of urgency urinary incontinence: a systematic review. Int J Clin Pract. 2013;67(10):1015–33. doi:10.1111/ijcp.12164.CrossRefPubMed

11.

Dmochowski RR, Newman DK. Impact of overactive bladder on women in the United States: results of a national survey. Curr Med Res Opin. 2007;23(1):65–76. doi:10.1185/030079907X159533.CrossRefPubMed

12.

Kinsey D, Pretorius S, Glover L, Alexander T. The psychological impact of overactive bladder: a systematic review. J Health Psychol. 2014. doi:10.1177/1359105314522084.PubMed

13.

Vrijens D, Drossaerts J, van Koeveringe G, Van Kerrebroeck P, van Os J, Leue C. Affective symptoms and the overactive bladder—a systematic review. J Psychosom Res. 2015;78(2):95–108. doi:10.1016/j.jpsychores.2014.11.019.CrossRefPubMed

14.

Coyne KS, Sexton CC, Clemens JQ, Thompson CL, Chen CI, Bavendam T, et al. The impact of OAB on physical activity in the United States: results from OAB-POLL. Urology. 2013;82(4):799–806. doi:10.1016/j.urology.2013.05.035.CrossRefPubMed

15.

Coyne KS, Sexton CC, Thompson CL, Clemens JQ, Chen CI, Bavendam T, et al. Impact of overactive bladder on work productivity. Urology. 2012;80(1):97–103. doi:10.1016/j.urology.2012.03.039.CrossRefPubMed

16.

Tang DH, Colayco DC, Khalaf KM, Piercy J, Patel V, Globe D, et al. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder. BJU Int. 2014;113(3):484–91. doi:10.1111/bju.12505.CrossRefPubMed

17.

Wu EQ, Birnbaum H, Marynchenko M, Mareva M, Williamson T, Mallett D. Employees with overactive bladder: work loss burden. J Occup Environ Med / Am Coll Occup Environ Med. 2005;47(5):439–46.CrossRef

18.

McKinlay JB, Link CL. Measuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) Survey. Eur Urol. 2007;52(2):389–96. doi:10.1016/j.eururo.2007.03.013.CrossRefPubMedPubMedCentral

19.

Irwin DE, Milsom I, Kopp Z, Abrams P. Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol. 2008;53(5):1029–37. doi:10.1016/j.eururo.2008.01.027.CrossRefPubMed

20.

Reynolds WS, McPheeters M, Blume J, Surawicz T, Worley K, Wang L, et al. Comparative effectiveness of anticholinergic therapy for overactive bladder in women: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(6):1423–32. doi:10.1097/AOG.0000000000000851.CrossRefPubMed

21.

Shamliyan T, Wyman JF, Ramakrishnan R, Sainfort F, Kane RL. Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review. Ann Intern Med. 2012;156(12):861–74. doi:10.7326/0003-4819-156-12-201206190-00436. W301-10.CrossRefPubMed

22.

Chancellor MB, Migliaccio-Walle K, Bramley TJ, Chaudhari SL, Corbell C, Globe D. Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder. Clin Ther. 2013;35(11):1744–51. doi:10.1016/j.clinthera.2013.08.017.CrossRefPubMed

23.

Sexton CC, Notte SM, Maroulis C, Dmochowski RR, Cardozo L, Subramanian D, et al. Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. Int J Clin Pract. 2011;65(5):567–85. doi:10.1111/j.1742-1241.2010.02626.x.CrossRefPubMed

24.

Hall SA, Link CL, Hu JC, Eggers PW, McKinlay JB. Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sample. BJU Int. 2009;104(11):1680–8. doi:10.1111/j.1464-410X.2009.08686.x.CrossRefPubMedPubMedCentral

25.

Maserejian NN, Minassian VA, Chen S, Hall SA, McKinlay JB, Tennstedt SL. Treatment status and risk factors for incidence and persistence of urinary incontinence in women. Int Urogynecol J. 2014;25(6):775–82. doi:10.1007/s00192-013-2288-3.CrossRefPubMed

26.

Benner JS, Nichol MB, Rovner ES, Jumadilova Z, Alvir J, Hussein M, et al. Patient-reported reasons for discontinuing overactive bladder medication. BJU Int. 2010;105(9):1276–82. doi:10.1111/j.1464-410X.2009.09036.x.CrossRefPubMed

27.

Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188(6 Suppl):2455–63. doi:10.1016/j.juro.2012.09.079.CrossRefPubMed

28.••

Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological A. Society of Urodynamics FPM. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193(5):1572–80. doi:10.1016/j.juro.2015.01.087. The AUA/SUFU Guidelines provide the most up-to-date, evidence-based guidelines for the diagnosis and treatment of OAB.CrossRefPubMed

29.

Ju R, Garrett J, Wu JM. Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States. Int Urogynecol J. 2013. doi:10.1007/s00192-013-2246-0.PubMed

30.

Subak L, Van Den Eeden S, Thom D, Creasman JM, Brown JS. Reproductive Risks for Incontinence Study at Kaiser Research G. Urinary incontinence in women: direct costs of routine care. Am J Obstet Gynecol. 2007;197(6):596. doi:10.1016/j.ajog.2007.04.029. e1-9.CrossRefPubMed

31.

Subak LL, Brown JS, Kraus SR, Brubaker L, Lin F, Richter HE, et al. The “costs” of qurinary incontinence for women. Obstet Gynecol. 2006;107(4):908–16. doi:10.1097/01.AOG.0000206213.48334.09.CrossRefPubMedPubMedCentral

32.••

Ganz ML, Smalarz AM, Krupski TL, Anger JT, Hu JC, Wittrup-Jensen KU, et al. Economic costs of overactive bladder in the United States. Urology. 2010;75(3):526–32. doi:10.1016/j.urology.2009.06.096. The authors use prevalence-based models and a variety of current published sources to calculate the most comprehensive estimate for the total US societal costs for OAB.CrossRefPubMed

33.

Onukwugha E, Zuckerman IH, McNally D, Coyne KS, Vats V, Mullins CD. The total economic burden of overactive bladder in the United States: a disease-specific approach. Am J Manag Care. 2009;15(4 Suppl):S90–7.PubMed

34.

Hu TW, Wagner TH, Bentkover JD, Leblanc K, Zhou SZ, Hunt T. Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology. 2004;63(3):461–5. doi:10.1016/j.urology.2003.10.037.CrossRefPubMed

35.

Hu TW, Wagner TH, Bentkover JD, LeBlanc K, Piancentini A, Stewart WF, et al. Estimated economic costs of overactive bladder in the United States. Urology. 2003;61(6):1123–8.CrossRefPubMed

Title: The Burden of Overactive Bladder on US Public Health
Authors: W. Stuart Reynolds
Jay Fowke
Roger Dmochowski
Publication date: 01-03-2016
Publisher: Springer US
Published in: Current Bladder Dysfunction Reports / Issue 1/2016
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-016-0344-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Burden of Overactive Bladder on US Public Health

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Current Treatment Options for Nonneurogenic Overactive Bladder in Children

The Bladder Is Not Sterile: History and Current Discoveries on the Urinary Microbiome

The Role of Mindfulness in Urinary Urgency Symptoms

Lessons Learned from Mesh Litigation for Prolapse and Incontinence

Impact of Caffeine on Overactive Bladder Symptoms

What Is the Impact of Overactive Bladder Symptoms on Female Sexual Function?